Substantial doubt about the company's ability to continue as a going concern.
“In the event that the Company does not complete a business combination by that date and is unable or does not obtain an extension, the Company will cease operations on that date. These matters raise substantial doubt about the Company's ability to continue as a going concern. The unaudited condensed financial statements do not include any adjustments that may be necessary should the Company be unable to continue as a going concern.”View the 10-Q filed Aug 14, 2026
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Globa Terra Acquisition Corporation seeks shareholder approval to extend its business-combination deadline from October 9, 2026 to July 9, 2027, using an initial one-month extension and up to eight additional one-month periods.
Nasdaq initiated delisting procedures for Globa Terra Acquisition Corporation after it missed its IPO business-combination deadline. The company plans to appeal by October 23, 2026, while seeking an extension to July 9, 2027.
Globa Terra Acquisition Corporation seeks approval to extend its Business Combination deadline from October 9, 2026 to July 9, 2027 through up to nine month-to-month extensions; otherwise, it expects to redeem public shares and liquidate.
Useful current figures from the complete screener profile.
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Illustrative technical + ownership context — a signal mix, not investment advice.
KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.
| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
GTERA
this stock
Globa Terra Acquisition Corp
|
$247.95M | +3.5% | — | — | 0.1% |
|
VYLR
Vylor Inc.
|
$45.73B | — | — | — | 2.2% |
|
CLUS
Cluster Group Holdings Ltd Co
|
$8.00B | — | — | — | — |
|
DMII
Drugs Made In America Acquisition II Corp.
|
$651.01M | +3.2% | — | — | 0.0% |
|
CCXI
Churchill Capital Corp XI
|
$627.18M | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
Globa Terra Acquisition Corporation seeks shareholder approval to extend its business-combination deadline from October 9, 2026 to July 9, 2027, using an initial one-month extension and up to eight additional one-month periods.
View| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| GTERA | -0.2% | +0.0% | +3.5% | -0.2% | +3.5% |
| SPY | -4.7% | -5.3% | -0.8% | -3.0% | +7.5% |
| vs SPY | +4.5% | +5.3% | +4.3% | +2.8% | -4.0% |
